Preview: Radiopharmaceuticals

The next wave of precision oncology

Radiopharmaceuticals and theranostics are opening new possibilities for cancer diagnosis and treatment by combining molecular targeting with radioactive isotopes. From radioligand therapies and targeted alpha emitters to ­imaging agents that help select patients and guide treatment, the field brings together drug discovery, nuclear medicine and specialist manufacturing. Translating these approaches into wider clinical use requires more than promising molecules: reliable isotope supplies, scalable production, coordinated logistics and access to treatment centers are essential.

Present your expertise

Drug developers, isotope producers, CDMOs, CROs, nuclear medicine specialists, equipment suppliers and technology providers will have the opportunity to present their latest products, processes and innovations in this special feature. European Biotechnology reaches decision-makers throughout the European life ­sciences sector and, through our official partner SLAS, in the USA. Showcase your expertise to potential customers and partners working across radiopharmaceutical development, manufacturing and clinical delivery. 

Examples of topics

Radioligand therapies, targeted alpha therapies, beta emitters, theranostics, novel tumor targets, targeting ­ligands and antibodies, chelator and linker chemistry, isotope production and supply, radiolabeling, process ­development, GMP manufacturing, automation and hot-cell technology, quality control, radiation protection, dosimetry, molecular imaging, patient selection, clinical trial design, regulatory strategy, specialist logistics and treatment access.

Interested in advertising with us? We’re happy to advise you!

Contact Marketing:
Oliver Schnell
Tel.: +49-30-264921-45
oliver.schnell@knowb.io

Andreas Macht
Tel.: +49-30-264921-54
andreas.macht@knowb.io